Yaohai Bio-Pharma has more than 15 years of experience in microbial cell line development and cell bank construction. Microbial cell line development and high-yield strain
Yaohai Bio-Pharma, a leading CRDMO focused on microbial expression systems, has announced the launch of its new microbial biologics platform. This platform brings together more
Yaohai Bio-Pharma has been awarded the 2025 Best CDMO for Customer Satisfaction, recognizing its excellence in CRDMO services, global partnerships, and innovation in biologics development.
